The research department at Woman’s Hospital is seeking participants for its SWEET Study to learn if a once-a-week medicine, called semaglutide (Ozempic®), can help proactively treat women who are at high risk for diabetes.
Women with a history of gestational diabetes in the last 10 years who are not menopausal and have pre-diabetes are invited to apply. Those who complete the eight-month study will be compensated $1,000.
Apply through Nov. 30 to be considered for the study by visiting womans.org.
Cardiovascular Institute of the South (CIS) is the first in the country to use the FreedomFlow® Orbital Atherectomy Platform to treat peripheral artery disease (PAD) in the legs. Drs. Pradeep Nair, McCall Walker, and Craig Walker used the new technology on Oct. 19 at Terrebonne General Health. This system by Cardio Flow, Inc. was FDA-cleared in late September.
Acadian Ambulance responded to multiple crashes in Louisiana and Texas as a result of severe foggy conditions. Fog combined with smoke from marsh fires created superfog conditions, extremely reducing visibility.